We are delighted to be joined by Prof David Armstong, Consultant Rheumatologist, WHSCT, host of the “BoneUp” Podcast and Clinical lead for Fracture Liaison & Osteoporosis who will be presenting with a refresher on the basics of osteoporosis, how the FRAX score is the basis for deciding on treatment now rather than just the DEXA, the vital importance of new vertebral fractures in predicting fracture risk, the concept of ‘Very High’ or ‘Imminent’ risk and the use of anabolic agents as a first line drug for these groups, and a mention of the new dual-action antibody Romosozumab, a new class of drug for osteoporosis.